Dear Editor,
Recent studies suggest that mitochondrial dynamics (fission and fusion) has a major impact on the regulation of mitochondrial outer membrane permeabilization,1, 2 which in turn determines the point-of-no-return of apoptotic and necrotic cell death.3 Thus, programmed cell death, as it occurs in Caenorhabditis elegans development, is accompanied by mitochondrial fragmentation. Overexpression of a dominant-negative (DN) mutant of dynamin-related protein-1 (DRP-1), which inhibits mitochondrial fission, can reduce the incidence of cell death induced by a BH3-only protein in vivo, in C. elegans.4 These data confirm prior observations obtained in vitro, in mammalian cell culture systems, in which a DN point mutant of human DRP-1 (DRP-1K38A)5 was found to inhibit mitochondrial fragmentation and cell death induced by different apoptosis inducers.6 Conversely, the overexpression of wild-type DRP-1, which causes extensive mitochondrial fragmentation without cell death, can inhibit apoptosis induction by ceramide in tumor cells, presumably by reducing the transmission of calcium waves through the cytoplasm.7
Mitochondrial fragmentation has been previously reported to affect the organs of HIV-1 carriers subjected to highly active antiretroviral therapy (HAART) and in particular to treatment with HIV-specific protease inhibitors.8, 9 Since some HIV-1-specific protease inhibitors such as ritonavir (Rtv) and nelfinavir (Nfv) can modulate apoptosis in vitro10 and in vivo, in mouse models of fulminant hepatitis, septic shock and temporary carotid occlusion,11 we investigated whether such protease inhibitors would regulate cell death via an effect on mitochondrial dynamics. To this end, we took advantage of syncytia, which due to their oversize offer a considerable advantage for light microscopic examination.12 Syncytia were generated by the fusion of HeLa cells expressing CD4 and HeLa cells expressing the HIV-1 envelope,13 then exposed to HIV-1 protease inhibitors at therapeutically achievable concentrations14 and monitored for mitochondrial morphology. Nfv, Rtv (Figure 1) and saquinavir (not shown) caused a marked fragmentation of the mitochondrial network into discrete, punctuate cytoplasmic dots, and this effect was partially inhibited by prior transfection with DRP-1K38A (Labrousse et al.5) (Figure 1a, b). Similarly, the knockdown of hFis1, another gene involved in nuclear fission,15 has a partial, yet highly significant inhibitory effect on mitochondrial fission induced by Nfv or Rtv (Figure 1b), underscoring that it involved specific (rather than nonspecific toxic) effects on mitochondrial dynamics. Thus, Nfv and Rtv can affect mitochondrial dynamics in a virus-free system, which lacks the HIV-1 protease. Importantly, Nfv and Rtv enforced mitochondrial fragmentation in conditions in which cytochrome c continued to be present in mitochondria and hence to colocalize with the mitochondrial marker Hsp60, as determined by two-color immunofluorescence (Figure 1a and b). HIV-1 Env-elicited syncytia undergo p53-dependent cell death after a latency period,16 as detectable by FACS analysis,17 and this phenomenon was not affected by Nfv or Rtv (Figure 1c). Moreover, Nfv or Rtv had no (positive or negative) effect on apoptosis induction induced by a CD95-agonistic antibody (7C11), staurosporine (STS) or acetylceramide (C2), as determined by FACS analysis of the mitochondrial transmembrane potential and cell viability18 (Figure 1d). In contrast to mitochondrial uncouplers, which can induce mitochondrial fragmentation while negatively affecting the mitochondrial transmembrane potential (ΔΨm),19, 20 Nfv or Rtv did not dissipate the ΔΨm (Figure 1d). Thus, a dramatic fragmentation of the mitochondrial network failed to induce apoptosis and even failed to modulate (facilitate or inhibit) apoptosis induction by endogenous or exogenous stimuli.
Apoptotic stimuli, like C2 ceramide and H2O2, induce Ca2+ release from the endoplasmic reticulum (ER),21 leading to Ca2+ uptake into the mitochondrial network. This process is initially limited to restricted areas (G Szabadkai, D De Stefani, R Rizzuto, unpublished), but then leads to mitochondrial Ca2+ overload, loss of mitochondrial membrane potential and release of proapoptotic factors (such as cytochrome c, AIF, or Omi/HtrA2) from the intermembrane space (for recent reviews see Garrido and Kroemer,22 and Danial and Korsmeyer23). Similarly, inositol 1,4,5-trisphosphate (IP3)-induced Ca2+ release leads to localized mitochondrial Ca2+ uptake, followed by intramitochondrial Ca2+ diffusion, resulting in complete Ca2+ charge of the entire network.7, 24 Division of the continuous mitochondrial network by Drp-1 (see above) disrupts these intramitochondrial Ca2+ waves, thus impeding the full mitochondrial Ca2+ upload. Importantly, reduced mitochondrial Ca2+ accumulation of the fragmented mitochondrial network has a protective role against Ca2+-mediated mitochondrial outer membrane permeabilization and apoptosis.1, 7 A prerequisite for this effect is that during mitochondrial division no change in the overall mitochondrial volume, subcellular localization and/or colocalization with the ER Ca2+ release sites occurs. Indeed, the overexpression of hFis1 in HeLa cells, apart from causing massive breakdown of the mitochondrial network, can also lead to perinuclear clustering of mitochondrial fragments. Parallel with these changes, no reduction in mitochondrial Ca2+ uptake could be observed following IP3-induced Ca2+ release in these cells,25 and importantly cells overexpressing hFis1 were more susceptible for apoptosis. Along these lines, using mitochondrially targeted recombinant Ca2+ sensitive probes, we assessed the overall and local Ca2+ mitochondrial signaling following IP3-mediated Ca2+ release in Nfv- and Rtv-treated HeLa cells. Division of the mitochondrial network induced by the HIV protease inhibitors led to a drastic reduction of intramitochondrial spreading of the Ca2+ signal (Figure 2a), as measured in single HeLa cells transfected with the mitochondrially targeted ratiometric pericam probe 2mtRP.7, 26 However, at variance with Drp-1-induced forced mitochondrial division,7 morphometric analysis of mtGFP-expressing Nfv- and Rtv- treated HeLa cells showed not only the fragmentation of the mitochondrial network, but also two other important morphological features: (i) fragmented mitochondrial particles were found to be clustered perinuclearly in both Nfv- and Rtv-treated cells (Figure 2c), and (ii) quantitative volume analysis revealed a significant decrease in mitochondrial number and volume for Rtv- and Nfv-treated cells, respectively, within the technical limitations of confocal microscropy (Figure 2b). A plausible consequence of these changes is the increase of ER–mitochondrial contacts relative to the mitochondrial volume, since the ER has a higher density in the perinuclear region. Indeed, population measurement in HeLa cells, transfected with the mitochondrially targeted low-affinity mutant aequorin (mtAEQmut) showed that the overall mitochondrial Ca2+ accumulation in Nfv- and Rtv-treated cells is more efficient, leading to higher [Ca2+] peak values during histamine-induced Ca2+ signals (Figure 2d). These findings explain why the compounds do not have protective effect against Ca2+-dependent apoptotic stimuli, and provide further insight into the mechanisms through which mitochondrial morphology may determine cellular fate in stress conditions.
In a further series of experiments, we investigated the effect of the cytomegalovirus early gene product viral mitochondrial inhibitor of apoptosis (vMIA)27, 28 (a product of the UL37 exon1 gene) on mitochondrial morphology. vMIA induced a marked shift from a tubular to a punctuate mitochondrial distribution (McCormick et al.29 and Supplementary Figure 1a), as detectable in normal HeLa cells.29 The vMIA-driven disintegration of the mitochondrial network was not modulated by transfection with DRP-1K38A nor by knockdown of hFis1 (Supplementary Figure 1b), although these genetic manipulations did have a significant impact on Nfv- or Rtv-induced mitochondrial fragmentation (Figure 1b). Moreover, DRP-1K38A or hFis1 knockdown did not antagonize the capacity of vMIA to inhibit apoptosis induction by CD95 activation (with 7C11) or general tyrosine kinase inhibition (with STS) (Supplementary Figure 1c). Thus, mitochondrial fragmentation mediated by vMIA is accompanied by strong apoptosis inhibition, and both phenomena are not affected by DRP-1K38A or hFis1.
As a result, we are confronted with two situations in which mitochondrial fragmentation does not lead to an enhanced mitochondrial permeabilization. In the first case, HIV-1 protease inhibitors reduce the connectivity of the mitochondrial network in a fashion that involves proteins of the fission/fusion machinery (such as Drp-1 and Fis1). In the second case, vMIA causes mitochondrial fragmentation through a different, yet to be elucidated pathway. However, in both cases reported here, mitochondrial fragmentation fails to induce apoptosis or to facilitate its induction, as this has been also reported for the simultaneous knockdown of hFis1 and Opa1.30 HIV-1 protease inhibitors were inert as far as cell death induction is concerned (Figure 1), although it has been reported that modulation of mitochondrial connectivity by Drp-1 and DRP-1K38A protects cells against ceramide and STS, respectively.6, 7 vMIA, which induces marked mitochondrial fragmentation, is – paradoxically – a rather potent, general inhibitor of MOMP and apoptosis.27, 28, 31 vMIA inhibits MOMP, presumably by recruiting Bax to mitochondria while antagonizing its pore-forming function.28, 32 However, vMIA can induce mitochondrial fragmentation in cells that lack Bax expression (not shown), indicating that the precise mechanism through which vMIA influences mitochondrial dynamics are elusive.
Irrespective of these incognita, however, it appears clear that mitochondrial fission is not automatically linked to apoptosis induction and that this link, if it exists, must be indirect and depends on cell types, the specific modulator of mitochondrial dynamics and/or the specific cell death inducer.
References
Perfettini J-L et al. (2005) Trends Cell Biol. 15: 179–183
Lucken-Ardjomande S and Martinou JC (2005) J. Cell Sci. 118: 473–483
Green DR and Kroemer G (2004) Science 305: 626–629
Jagasia R et al. (2005) Nature 433: 754–760
Labrousse AM et al. (1999) Mol. Cell. 4: 815–826
Frank S (2001) Dev. Cell 1: 515–525
Szabadkai G et al. (2004) Mol. Cell. 8: 59–68
Tolomeo M et al. (2003) J. Clin. Pathol. 56: 147–151
Verucchi G et al. (2004) J. Acquir. Immune Defic. Syndr. 35: 326–328
Phenix BN (2001) Blood 98: 1078–1085
Weaver JGR et al. (2005) J. Clin. Invest. 115: 1828–1938
Castedo M and Kroemer G. (2002) Trends Cell Biol. 12: 446–447
Castedo M et al. (2002) EMBO J. 21: 4070–4080
Badley AD et al. (2003) Trends Pharmacol Sci. 24: 298–305
James DI et al. (2003) J. Biol. Chem. 278: 36373–36379
Boya P et al. (2005) Mol. Cell. Biol. 25: 1025–1040
Roumier T et al. (2003) Biochem. Pharmacol. 66: 1321–1329
Castedo M et al. (2002) J. Immunol. Methods 265: 39–47
Legros F et al. (2002) Mol. Biol. Cell. 13: 4343–4354
Lyamzaev KG et al. (2004) Biochem. Soc. Trans. 32: 1070–1071
Pinton P et al. (2001) EMBO J. 20: 2690–2701
Garrido C. and Kroemer G (2004) Curr. Opin. Cell Biol. 16: 639–646
Danial NN and Korsmeyer S. (2004) Cell 116: 205–219
Gerencse AA and Adam-Vizi V (2005) Biophys. J. 88: 698–714
Frieden M et al. (2004) J. Biol. Chem. 279: 22704–22714
Filippin L et al. (2003) J. Biol. Chem. 278: 39224–39234
Goldmacher VS et al. (1999) Proc. Natl. Acad. Sci. USA 96: 12536–12541
Poncet D et al. (2004) J. Biol. Chem. 279: 22605–22614
McCormick AL et al. (2003) J. Virol. 77: 631–641
Lee YL et al. (2004) Mol. Biol. Cell. 15: 5001–5011
Castedo M et al. (2004) Oncogene 23: 4362–4370
Arnoult D et al. (2004) Proc. Natl. Acad. Sci. USA 101: 7988–7993
Bianchi K et al. (2004) Biochim. Biophys. Acta 1742: 119–131
Chiesa A et al. (2001) Biochem. J. 355: 1–12
Carrington WA et al. (1995) Science 268: 1483–1487
Acknowledgements
We thank Dr. AM van der Bliek (University of California Los Angeles, CA, USA) and JC Martinou (University of Geneva, Switzerland) for expression and siRNA vectors, respectively. This work has been supported by a special grant from the Ligue Nationale contre le Cancer, grants from ANRS and the European Commission (to GK), Telethon-Italy (Grants no. 1285 and GTF02013), the Italian Association for Cancer Research (AIRC), the Human Frontier Science Program, the Italian University Ministry (MURST and FIRB) and the Italian Space Agency (ASI) (to RR).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary information accompanies the paper on Cell Death and Differentiation website (http://www.nature.com/cdd)
Supplementary information
Rights and permissions
About this article
Cite this article
Roumier, T., Szabadkai, G., Simoni, AM. et al. HIV-1 protease inhibitors and cytomegalovirus vMIA induce mitochondrial fragmentation without triggering apoptosis. Cell Death Differ 13, 348–351 (2006). https://doi.org/10.1038/sj.cdd.4401750
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4401750
This article is cited by
-
Mitochondria-associated membranes (MAMs) and inflammation
Cell Death & Disease (2018)
-
The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability
Molecular Neurobiology (2016)
-
Unexpected role of the phosphate carrier in mitochondrial fragmentation
Cell Death & Differentiation (2008)